Aisling Capital related stories
All articles and analysis
- CalPERS Dumps A Ton of Docs
CalPERS today released more than 5,000 pages worth of documents related to placement agents used to secure investments from the pension system. These are based on a recent CalPERS board request that each of its general partners provide information on who, if anyone, helped place the funds and how much was paid in fees. The submissions were voluntary, with approximately 90% of CalPERS investees replying. We're awaiting a list of the 10% that declined (a CalPERS spokeswoman said that she'd rustle one up). We have posted almost all of the disclosure forms from VC and private equity firms, although not the ones from real estate funds and certain special purpose vehicles (there's simply too much stuff). If there's a headline, it's probably that ARVCO -- the placement agency run by former CalPERS board member Alfred Villalobos -- received far more in fees (we're talking multiples) than did any other placement agent. Also the continuing story about how CalPERS has been a huge proponent of investment transparency and quality corporate governance over the years, but apparently neglected to do some fundamental recordkeeping for its own activities. Find tons of documents after the jump. Part II can be found here /60813/calpers-doc-dump/
- Durata Therapeutics Launches, Buys Virucon Pharma
Durata Therapeutics Inc., an antibiotic development platform recently formed by five venture capital firms, has acquired Vicuron Pharmaceuticals, developer of an antibiotic drug candidate called dalbavancin, from Pfizer. No financial terms were disclosed. Durata's backers are New Leaf Venture Partners, Domain Associates, Aisling Capital, Sofinnova Ventures and Canaan Partners.
- peHUB Wire: Monday, December 21, 2009
Monday Mouth-Off
- peHUB Wire: Monday, December 21, 2009
Monday Mouth-Off
- Exit watch, week of Nov. 23, 2009
News briefs about LifeSize, AdMob, MontaVistaGizmo5, Imeem and other VC-backed companies that were bought in the past week
- Bioniche Pharma Adds On
Bioniche Pharma, an injectable drugmaker owned by Roundtable Healthcare Partners, has acquired Duraclon (clonidine hydrochloride injection) and Methadone Hydrochloride Injection USP from Xanodyne Pharmaceuticals Inc. No financial terms were disclosed. Xanodyne has raised over $230 million in VC funding, from firms like AIG Investments, Aisling Capital, Blue Chip Venture Co., Essex Woodlands Health Ventures, HealthCare Ventures, MPM Capital and Union Springs.
- peHUB Wire: Monday, November 16, 2009
Random Ramblings
- peHUB Wire: Monday, November 16, 2009
Random Ramblings
- Week in deals, Oct. 12, 2009
A summary of North American tech companies and other businesses that raised venture financing in the past week